Wisevoter
World

Researchers Identified New Pathogenic ALS Mechanism

A study uncovered how TBK1 loss of function triggers a specific form of cell death in motor neurons.

Updated on Sept. 21, 2026 in Alzheimer’s

Macro photograph of bioluminescent neuronal cellular structures with complex branched filaments against a dark navy background.
Researchers identified a new pathogenic mechanism in ALS, where TBK1 gene loss of function triggers a specific form of neuronal cell death. AI Illustration. Upload story photo >

Scientists have identified a shared pathogenic mechanism in ALS patients involving the loss of function of the TBK1 gene. This process triggers a pyroptotic program that results in the damage and eventual death of motor neurons.

Why it matters

The discovery reveals that the TBK1-caspase-GSDME axis plays a critical role in neurodegeneration. This identification provides a new potential target for disease-modifying therapies in ALS patients.

Whole-exome sequencing identified pathogenic variants in 3 out of 8 familial ALS patients. The research remains focused on laboratory-based molecular pathways and murine models.

The players

TBK1

This gene produces a protein kinase involved in neuroinflammation and intracellular signaling pathways.

TDP-43

This protein is frequently associated with proteinopathies in neurodegenerative conditions like ALS.

The details

Patient-derived motor neurons showed significant axonal and neurite shortening alongside reduced TBK1 activity. These cells exhibited an increase in phosphorylated TDP-43 and a co-assembly of caspase-8/7 and gasdermin E, which drives cell destruction under neuroinflammatory stimulation.

Timeline

  1. September 21, 2026: The research findings were formally published.

The Big Picture

This discovery extends the current understanding of the TBK1-caspase-GSDME axis as a primary driver of neuronal loss in neurodegenerative diseases.

The findings define a specific biological pathway that may guide the development of future targeted ALS medications. This research does not currently change existing diagnostic or treatment protocols for patients.

The takeaway

Understanding the specific molecular pathways that lead to motor neuron death is essential for advancing ALS drug development. Future treatments may focus on modulating the caspase-GSDME axis to prevent cellular damage.

Further reading

Learn more about the latest developments in neurodegenerative research in our Alzheimer’s section.

More information

Read the complete scientific research article for technical details on the study.

Source note: This article includes information reported by Nature.